Rapid onset demand Opportunity to partner with dermatology clinics, podiatry practices, pediatrics, and cosmetic/aesthetic medicine providers that require fast-acting topical anesthetics, leveraging Sambria’s trans-dermal delivery as a differentiator.

Independent reps Current growth strategy centers on independent representatives and regional distributors; sales outreach should target relationship-driven agents with established clinician networks across the United States.

Strategic partnerships Recent collaboration with MD Needle Pen indicates potential co-marketing or bundled offerings; explore additional partnerships with medical device and aesthetic product distributors to expand channel reach.

Market readiness Small but scalable revenue profile with OTC and topical anesthetic focus positions Sambria for opportunistic contracts with clinics, dermatology centers, and cosmetic treatment providers seeking rapid anesthetic solutions.

Tech and visibility Utilize existing tech stack and web assets to support lead generation, clinician education, and product demonstrations; emphasize rapid onset benefits and specialized indications in outreach materials.